Miller Howard Investments Inc. NY lowered its stake in Nutrien Ltd. (NYSE:NTR – Free Report) by 1.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 610,343 shares of the company’s stock after selling 8,568 shares during the period. Miller Howard Investments Inc. NY’s holdings in Nutrien were worth $37,670,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds also recently bought and sold shares of NTR. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Nutrien by 65.1% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,224 shares of the company’s stock worth $1,253,000 after acquiring an additional 9,950 shares in the last quarter. NewEdge Advisors LLC raised its position in shares of Nutrien by 6.2% during the 1st quarter. NewEdge Advisors LLC now owns 6,907 shares of the company’s stock worth $343,000 after acquiring an additional 404 shares in the last quarter. Focus Partners Wealth acquired a new stake in shares of Nutrien during the 1st quarter worth about $516,000. Acadian Asset Management LLC acquired a new stake in shares of Nutrien during the 1st quarter worth about $54,000. Finally, Prudential Financial Inc. acquired a new stake in shares of Nutrien during the 2nd quarter worth about $203,000. Institutional investors and hedge funds own 63.10% of the company’s stock.
Analyst Upgrades and Downgrades
Several brokerages have recently weighed in on NTR. JPMorgan Chase & Co. raised their target price on Nutrien from $68.00 to $78.00 and gave the stock an “overweight” rating in a research report on Friday, February 20th. Scotiabank raised their target price on Nutrien from $63.00 to $70.00 and gave the stock a “sector perform” rating in a research report on Monday, February 2nd. Jefferies Financial Group raised Nutrien from a “hold” rating to a “buy” rating and raised their target price for the stock from $74.00 to $96.00 in a research report on Thursday, March 12th. BNP Paribas Exane lowered Nutrien from an “outperform” rating to a “neutral” rating in a research report on Monday, February 23rd. Finally, Wall Street Zen lowered Nutrien from a “buy” rating to a “hold” rating in a research report on Sunday, April 12th. Ten analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, Nutrien presently has a consensus rating of “Hold” and an average target price of $79.65.
Nutrien News Summary
Here are the key news stories impacting Nutrien this week:
- Positive Sentiment: Zacks raised a couple of near‑term quarter forecasts (Q3 2026 to $0.75 from $0.72; Q2 2027 to $1.87 from $1.84), which slightly offsets cuts elsewhere and could support near‑term earnings visibility. MarketBeat Zacks upgrades
- Neutral Sentiment: Mizuho reiterated a Hold on NTR (reported as “Gets a Hold”), a neutral signal that suggests no immediate change in sell‑side conviction. Nutrien (NTR) Gets a Hold from Mizuho Securities
- Negative Sentiment: Unusually large put buying: traders purchased ~14,187 put contracts on Friday (about 88% above the average put volume), signaling increased hedging or directional bearish bets that can amplify downside pressure on the stock. Options flow report
- Negative Sentiment: Zacks Research issued a string of downward revisions across multiple periods — trimming EPS for Q2 2026, Q4 2026, Q1 2027, Q4 2027 and lowering FY2026–FY2028 estimates (while keeping a Hold rating). The cuts reduce near‑ and medium‑term earnings expectations and likely prompted some investor selling. Zacks still cites a consensus full‑year figure (reported there) but has lowered several company forecasts. MarketBeat — Zacks estimate revisions
Nutrien Trading Up 0.0%
NTR opened at $70.64 on Monday. The firm has a market cap of $33.96 billion, a price-to-earnings ratio of 15.16 and a beta of 0.69. Nutrien Ltd. has a 52 week low of $51.98 and a 52 week high of $85.36. The business’s 50 day moving average is $74.53 and its two-hundred day moving average is $65.81. The company has a quick ratio of 0.70, a current ratio of 1.34 and a debt-to-equity ratio of 0.37.
Nutrien (NYSE:NTR – Get Free Report) last released its quarterly earnings results on Wednesday, February 18th. The company reported $0.83 EPS for the quarter, missing the consensus estimate of $0.87 by ($0.04). The firm had revenue of $5.12 billion for the quarter, compared to analyst estimates of $5.26 billion. Nutrien had a return on equity of 8.41% and a net margin of 8.43%.The company’s quarterly revenue was up 5.1% on a year-over-year basis. During the same period last year, the firm earned $0.31 EPS. On average, research analysts predict that Nutrien Ltd. will post 3.72 EPS for the current year.
Nutrien Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Thursday, April 16th. Shareholders of record on Tuesday, March 31st were given a dividend of $0.55 per share. This represents a $2.20 annualized dividend and a yield of 3.1%. This is a positive change from Nutrien’s previous quarterly dividend of $0.55. The ex-dividend date of this dividend was Tuesday, March 31st. Nutrien’s dividend payout ratio is presently 47.21%.
Nutrien Company Profile
Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.
Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.
Further Reading
Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTR – Free Report).
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.
